German Man Says Indians Have Good Dental Hygiene, Internet Divided
A Germany-based employee's Reddit post on his Indian co-workers' dental hygiene has gone viral, sparking a conversation online. In his post, the user asked: "Why do many Indians have such good teeth?". He said that he has noticed that many of his Indian co-workers have white, well-maintained teeth. He wrote that he has wondered about this for a while, and asked the Reddit community if this was because of diet, different dental care habits or traditional remedies or cultural practices.
"I've noticed that many of my Indian coworkers here in Germany have really good teeth - they're white, well-maintained, and there's never any bad breath. I've been wondering about this for a while. Is it due to diet? Different dental care habits? Traditional remedies or cultural practices? I'm genuinely curious because I've noticed this with several people, and I'd love to understand what might be behind it. Maybe someone here can share some insights or personal experiences?" the Redditor wrote.
by u/ConditionSilent3295 in indiasocial
The post quickly caught the attention of social media users, prompting several interesting remarks. While some explained the reason, others shared stories about the poor dental hygiene of people they had encountered.
"Brush twice a day and tongue clean, don't eat anything unless you brush your teeth. It was a major culture shock to me that people in western countries, especially Americans go about their day and have their breakfast before brushing their teeth in the morning. I can't even imagine doing something like that," wrote one user.
"There are so many things in daily habits such as gargling, tongue cleaning, etc. which are not so big in th west then again, there is dietary habits such as drinking milk and yet eating less cheese and meat also helps with breath and teeth hygeine," explained another.
However, one user wrote, "OP lives in a bubble. As a doctor, i can personally vouch Indians have some of the poorest dental care, coverage. Most dentists I've worked with, oropharyngeal surgeons would also concur with this view."
"lol which indians? everyone's mouth here is stained red by chewing tobacco, as demonstrated by all the wonderful red streaks on almost every public building," commented another.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Breaking News Live Updates: Australia, Canada, New Zealand, Norway, UK announce sanctions against Israel ministers
06:20 (IST) Jun 12 Srinivas "Bobby" Mukkamala has been elected President of the American Medical Association, becoming the first person of Indian origin to lead the organisation in its 178-year history. Recently recovering from brain tumour surgery, Mukkamala said his experience reaffirmed his commitment to advocating for a more equitable US health system.
Hindustan Times
an hour ago
- Hindustan Times
Hundreds of laid-off CDC employees in US are being reinstated
More than 460 laid-off employees at the nation's top public health agency received notices Wednesday that they are being reinstated, according to a union representing the workers. The US Department of Health and Human Services confirmed reinstatement notices went out to the former Centers for Disease Control and Prevention employees, but provided few details. About 2,400 CDC employees lost their jobs in a wave of cuts across federal health agencies in early April, according to a tally at the time. Whole CDC programs were essentially shut down, including some focused on smoking, lead poisoning, gun violence, asthma and air quality, and workplace safety and health. The entire office that handles Freedom of Information Act requests was shuttered. Infectious disease programs took a hit, too, including programs that fight outbreaks in other countries, labs focused on HIV and hepatitis in the US, and staff trying to eliminate tuberculosis. An estimated 200 of the reinstated workers are based in the CDC's National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention, HHS officials confirmed. Staffers at a CDC lab that does testing for sexually transmitted diseases are being brought back, said one CDC employee who wasn't authorized to discuss what happened and spoke to The Associated Press on condition of anonymity. Also reinstated are an estimated 150 employees at the CDC's National Center for Environmental Health, including people staffing a lab that works on lead poisoning, according to the union and employees. Layoffs at federal agencies were challenged in lawsuits, with judges in some cases ordering federal agencies to halt terminations of employees. Officials at HHS have never detailed how they made the layoff decisions in the first place. And they did not answer questions about why the notices went out, or how decisions were made about who to bring back. HHS spokesperson Andrew Nixon said the agency was streamlining operations and that 'the nation's critical public health functions remain intact and effective.' "The Trump Administration is committed to protecting essential services — whether it's supporting coal miners and firefighters through NIOSH, safeguarding public health through lead prevention, or researching and tracking the most prevalent communicable diseases,' he said. The reinstatements don't undo the damage being done by Kennedy and the Trump administration to federal public health, said members of Fired But Fighting, a group of affected CDC workers who have helped organize rallies in Atlanta. The most recent was in the rain on Tuesday, at which some attendees called for Kennedy to resign. 'Bringing a few hundred people back to work out of thousands fired is a start, but there are still countless programs at CDC that have been cut, which will lead to increased disease and death,' one of the group's founding members, Abby Tighe, said in a statement. This is not the first time that employees at the Atlanta-based agency were told they were being terminated only to then be told to come back. After an earlier round of termination notices went out in February, about 180 CDC employees in March were told to come back.
Mint
2 hours ago
- Mint
These diabetes drugs are finding new life as an antiaging hack
Some health-obsessed Americans believe the next antiaging therapeutic already exists—in the medicine cabinets of millions of diabetes patients. The widely used class of drugs, called SGLT2 inhibitors and sold under brand names such as Jardiance and Farxiga, have been on the market for over a decade as Type 2 diabetes medications. They have also gained regulatory approval to treat conditions like heart failure and kidney disease. Recently, though, the drugs have emerged as a hot topic on popular health podcasts and Reddit forums for longevity enthusiasts, many of whom don't suffer from any of those conditions. Instead, they are adding SGLT2 inhibitors to a roster of hacks they hope will help them live healthier for longer—or in other words, increase their healthspan. The drugs work by helping the kidneys release extra glucose from the body through urine, improving blood-sugar levels. While there are no studies of whether they can extend the lives of healthy humans, a growing body of evidence shows they help protect against multiple age-related diseases and reduce mortality rates for patients with certain chronic conditions. Some researchers believe they may also affect the fundamental biology of aging. 'This is probably the drug class of our era," says Dr. Timothy Gong, section physician leader for heart failure and transplant cardiology at Baylor University Medical Center, who has researched SGLT2 inhibitors. 'You see cardiologists, nephrologists, endocrinologists, even general internists as well, just getting so excited." Gong says he wouldn't be surprised to take an SGLT2 inhibitor one day, once they are studied more, though he's free from heart issues and diabetes. Yet it's too early to prescribe it for longevity benefits in otherwise healthy patients. 'I don't think that the evidence is strong enough yet for us to be able to say that," he says. Right now, use of SGLT2 inhibitors for potential antiaging benefits is limited mostly to a growing community of so-called biohackers, who seek to optimize their health through experimentation with gadgets, behaviors and various medicines and supplements. Because most take it off-label—meaning, for a nonapproved use—the drugs typically aren't covered by insurance and can cost hundreds of dollars a month out of pocket. Dave Aiello, a Boston chiropractor who doesn't have diabetes, began experimenting with the drugs after learning about a promising study in mice. The 38-year-old wanted to get ahead of health problems but was disenchanted by what he saw as a reactive approach to disease in conventional medicine. 'I'm trying to see if I can just stay as healthy as possible for as long as possible," says Aiello, who has been taking an SGLT2 inhibitor called empagliflozin since 2022. He also takes the kidney-transplant drug rapamycin off-label and has previously taken the diabetes pill metformin—both of which have gained traction as potential longevity boosters, too. He was particularly impressed by research showing SGLT2 inhibitors can help the body manage blood sugar more efficiently, which in turn supports cardiometabolic health. He says he's encouraged by the results so far: Between 2022 and 2024, Aiello's hemoglobin A1C, a measure of average blood sugar, fell to 4.6% from 5.1%, his laboratory test results show. The drugs aren't free of potential side effects, including increased risk of urinary-tract infections, dehydration, and in rare cases, severe genital infections and a life-threatening condition called diabetic ketoacidosis. When Aiello first started taking empagliflozin, he felt dehydrated and experienced fatigue and brain fog. Those side effects have subsided since he decreased his dose and has made sure to take in more electrolytes. 'I'm a little more willing to take some risks that could potentially affect me in the short term if I do think that there might be a benefit," Aiello says. It isn't clear precisely how SGLT2 inhibitors might protect against the ravages of aging, but the research in mice offers clues. In 2020, a National Institute on Aging-funded study found that one SGLT2 inhibitor called canagliflozin extended the lives of male—but not female—mice by 14%. One theory is that the drugs help slow the aging process partly by blunting blood-sugar spikes. Scientists say that by driving insulin levels down, these drugs promote fat burning and create an anti-inflammatory effect that mimics calorie restriction, which studies suggest can slow the pace of aging. Still, many drugs that work in mice don't work in humans, says Richard A. Miller, who led the study and is director of the Glenn Center for Biology of Aging Research at the University of Michigan. His lab is now studying how the small molecules inside slow-aging mice change over time. If a drug in humans produces these same metabolomic shifts seen in slow-aging mice, he says, it would provide more confidence that it could slow aging in people. 'We still have a lot of work to do to prove that the drugs do the same thing in people," says Miller. 'The hint here is that it's actually slowing the aging rate." Alan Vuong, who works in sales in Austin, Texas, started taking the SGLT2 inhibitor dapagliflozin this year after hearing a podcast interview with Miller. The 34-year-old has a family history of Type 2 diabetes and wanted to lower his fasting insulin level, a measure of metabolic health, from normal to optimal. He spends about $150 a month on his longevity protocol, which includes a dozen drugs and supplements, and has seen his insulin levels drop since starting the medication. Other than having to use the bathroom in the middle of the night more often, a known side effect of the drugs, Vuong hasn't noticed other physical side effects. 'My end goal is to extend lifespan, but more importantly, healthspan," he says. 'I'm willing to take that gamble."
